OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
December 03, 2022
Unique solutions are required to protect inherently unstable messenger RNA.
October 12, 2022
CBER maps modernization plan to handle surge in research and applications.
October 02, 2022
Awareness of recently implemented—or ongoing—advances by the pharmacopoeias can help biotherapeutic manufacturers remain compliant with current requirements.
August 04, 2022
Synthego has launched new engineered cell libraries to validate targets for quicker drug discovery timelines.
August 03, 2022
Further advances in construct design and manufacturing scalability are still needed.
August 02, 2022
Novasep-PharmaZell will increase API production capacity at its Mourenx site with €7.3M investment.
July 08, 2022
VeriSIM Life and Mayo Clinic are collaborating to develop new promising drug candidates.
LG Chem has decided to proceed with IND-enabling studies and has renewed a license with Avacta.
June 27, 2022
ImmunoGen has formed a research collaboration with Oxford BioTherapeutics to develop novel antibody-drug conjugates for cancers with high unmet needs.
May 26, 2022
Lonza and Israel Biotech Fund form a two-year agreement to support accelerated development and manufacture of biologics and small molecules.